Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1): novel therapeutic targets for angiogenic disorders.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12543719
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy.

  2002cited by this paper
• Myocardial gene therapy

  2002cited by this paper
• Cyclooxygenase-2 Promotes Early Atherosclerotic Lesion Formation in LDL Receptor–Deficient Mice

  2002cited by this paper
• The genetic and immunopathological processes underlying collagen‐induced arthritis

  2001cited by this paper
• Time course of arteriogenesis following femoral artery occlusion in the rabbit.

  2001cited by this paper
• Rheumatoid arthritis.

  2001cited by this paper
• Therapeutic angiogenesis in cardiology using protein formulations.

  2001cited by this paper
• Role of vascular endothelial growth factor in regulation of physiological angiogenesis.

  2001cited by this paper
• Angiozyme: A Novel angiogenesis inhibitor

  2001cited by this paper
• Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

  2001cited by this paper
• Structure and function of VEGF/VEGF-receptor system involved in angiogenesis.

  2001cited by this paper
• Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis.

  2001cited by this paper
• Expression of vascular endothelial growth factor receptors in smooth muscle cells

  2001cited by this paper
• Angiogenesis-dependent diseases.

  2001cited by this paper
• Growing better blood vessels

  2001cited by this paper
• Plaque angiogenesis and atherosclerosis.

  2001cited by this paper
• Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice.

  2001cited by this paper
• What have we learned about the biology of atherosclerosis? The role of inflammation.

  2001cited by this paper
• Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque.

  2001cited by this paper
• Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease.

  2001cited by this paper
• Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

  2001cited by this paper
• Angiogenesis in cancer and other diseases

  2000cited by this paper
• VEGF gene therapy: stimulating angiogenesis or angioma-genesis?

  2000cited by this paper
• Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor

  2000cited by this paper
• Regulation of angiogenesis via vascular endothelial growth factor receptors.

  2000cited by this paper
• Mechanisms of angiogenesis and arteriogenesis

  2000cited by this paper
• Treatment with Soluble VEGF Receptor Reduces Disease Severity in Murine Collagen-Induced Arthritis

  2000cited by this paper
• Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary.

  2000cited by this paper
• Angiogenesis in inflammatory joint disease: a target for therapeutic intervention

  2000cited by this paper
• Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype.

  2000cited by this paper
• Placenta growth factor (PlGF) induces vascular endothelial growth factor (VEGF) secretion from mononuclear cells and is co‐expressed with VEGF in synovial fluid

  2000cited by this paper
• Structure, expression and receptor-binding properties of placenta growth factor (PlGF).

  1999cited by this paper
• Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188

  1999cited by this paper
• Immunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries.

  1998cited by this paper
• Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb.

  1998cited by this paper
• Functions of the VEGF receptor-1 (FLT-1) in the vasculature.

  1998cited by this paper
• Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.

  1998cited by this paper
• Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury.

  1996cited by this paper
• Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

  1995cited by this paper
• Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms.

  1994cited by this paper
• Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.

  1994cited by this paper
• Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression.

  1979cited by this paper

• Injectable BMSC‐Based Extracellular Matrix‐Mimicking Microtissue for Myocardial Infarction Repair

  2025cites this paper
• Unveiling the association between angiogenic imbalance in the gingival crevicular fluid in maternal periodontitis and spontaneous preterm birth

  2025cites this paper
• A Comprehensive Review of Clinically Applied Adeno-Associated Virus-Based Gene Therapies for Ocular Disease

  2025cites this paper
• Placental cell type deconvolution reveals that cell proportions drive preeclampsia gene expression differences

  2023cites this paper
• History of peripheral artery disease and cardiovascular risk of real-word patients with acute coronary syndrome: Role of inflammation and comorbidities.

  2023cites this paper
• Analysis of the potential association between ferroptosis and immune in hepatocellular carcinoma and their relationship with prognosis

  2023cites this paper
• Changes in concentrations of melatonin, PlGF, and cytokines in women with preeclampsia

  2023cites this paper
• Molecular and spatial landmarks of early mouse skin development.

  2023cites this paper
• Uncovering the Heterogeneity of Cardiac Lin -KIT + Cells: A scRNA-seq Study on the Identification of Subpopulations.

  2023cites this paper
• A distinct class of hematopoietic stem cells develop from the human yellow bone marrow

  2023cites this paper
• Vitamins and their derivatives synergistically promote hair shaft elongation ex vivo via PlGF/VEGFR-1 signalling activation.

  2022cites this paper
• Myocardial Protection and Current Cancer Therapy: Two Opposite Targets with Inevitable Cost

  2022influential citation
• Soluble Fms-like tyrosine kinase-1 (sFlt-1) is associated with subclinical and clinical atherosclerotic cardiovascular disease: The Dallas Heart Study.

  2022cites this paper
• Angiogenic stimulation strategies in bone tissue regeneration.

  2022cites this paper
• Peripheral vascular disease: preclinical models and emerging therapeutic targeting of the vascular endothelial growth factor ligand-receptor system

  2021cites this paper
• FKBPL and SIRT-1 Are Downregulated by Diabetes in Pregnancy Impacting on Angiogenesis and Endothelial Function

  2021cites this paper
• Nanodrug Delivery Systems Modulate Tumor Vessels to Increase the Enhanced Permeability and Retention Effect

  2021cites this paper
• Male Fetal Sex Affects Uteroplacental Angiogenesis in Growth Restriction Mouse Model†.

  2021cites this paper
• New Directions in Therapeutic Angiogenesis and Arteriogenesis in Peripheral Arterial Disease

  2021cites this paper
• Dual Stem Cell Therapy Improves the Myocardial Recovery Post-Infarction through Reciprocal Modulation of Cell Functions

  2021cites this paper
• Promotion of Proangiogenic Secretome from Mesenchymal Stromal Cells via Hierarchically Structured Biodegradable Microcarriers

  2020cites this paper
• Angiogenic Networks in Tumors—Insights via Mathematical Modeling

  2020cites this paper
• Stromal Cells Promote Neovascular Invasion Across Tissue Interfaces

  2020cites this paper
• Melatonin Levels Decrease in the Umbilical Cord in Case of Intrauterine Growth Restriction

  2020cites this paper
• Sequential Treatment with Bevacizumab and Aflibercept for Metastatic Colorectal Cancer in Real-World Clinical Practice

  2020cites this paper
• The Association of Angiogenesis Markers With Acute Kidney Injury and Mortality After Cardiac Surgery.

  2019cites this paper
• Placenta growth factor and sFlt-1 as biomarkers in ischemic heart disease and heart failure: a review.

  2019cites this paper
• The Role of Angiogenesis and Pro-Angiogenic Exosomes in Regenerative Dentistry

  2019influential citation
• Early Post-stroke Activation of Vascular Endothelial Growth Factor Receptor 2 Hinders the Receptor 1-Dependent Neuroprotection Afforded by the Endogenous Ligand

  2019cites this paper
• Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases.

  2019cites this paper
• Accelerated growth of hemangioblastoma in pregnancy: the role of proangiogenic factors and upregulation of hypoxia-inducible factor (HIF) in a non-oxygen-dependent pathway

  2019cites this paper
• A biomaterials approach for therapeutic angiogenesis

  2019cites this paper
• Cellular and molecular mechanisms of kidney fibrosis.

  2019cites this paper
• A Combinatorial Cell and Drug Delivery Strategy for Huntington’s Disease Using Pharmacologically Active Microcarriers and RNAi Neuronally-Committed Mesenchymal Stromal Cells

  2019cites this paper
• The Anti–Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo

  2018cites this paper
• Angiogenic Self-Assembling Peptide Scaffolds for Functional Tissue Regeneration.

  2018cites this paper
• Sorafenib Reveals Anti-Arthritic Potentials in Collagen Induced Experimental Arthritis Model.

  2018cites this paper
• Human amnion extracellular matrix derived bioactive hydrogel for cell delivery and tissue engineering.

  2018cites this paper
• Activation of brown adipocytes by placental growth factor.

  2018cites this paper
• Binding of Resveratrol to Vascular Endothelial Growth Factor Suppresses Angiogenesis by Inhibiting the Receptor Signaling.

  2018cites this paper
• Development of a first trimester prediction model for preeclampsia and prospective validation in a multicentre setting

  2018cites this paper
• Chronic Placental Inflammation as a Risk Factor of Severe Retinopathy of Prematurity

  2018cites this paper
• METHODS OF PROGNOSIS AND DAGNOSIS IN CHRONIC HEART FAILURE RELATED APPLICATION INFORMATION

  2017cites this paper
• Extracorporeal Shockwave Therapy for Peripheral Arterial Disease: A Review of the Potential Mechanisms of Action.

  2017cites this paper
• Physiological and pathological angiogenesis in endometrium at the time of embryo implantation

  2017cites this paper
• Mechanisms of macular edema: Beyond the surface.

  2017cites this paper
• Pharmacologic Therapy of Ocular Disease

  2017cites this paper
• Homocysteine Facilitates Prominent Polygonal Angiogenetic Networks of a Choroidal Capillary Sprouting Model.

  2017cites this paper
• Anti-angiogenic Therapy for Retinal Disease.

  2017cites this paper
• Flt-1-positive cells are cancer-stem like cells in colorectal carcinoma

  2017influential citation
• Placenta growth factor mediated gene regulation in sickle cell disease.

  2017cites this paper
• Interleukin-8: A potent promoter of angiogenesis in gastric cancer.

  2016cites this paper
• First trimester prediction of the 'small for gestational age' fetus

  2016cites this paper
• Screening for preeclampsia

  2016cites this paper
• "Fishing" out the real VEGFs.

  2016cites this paper
• Novel indexes of arrhythmogenesis in preeclampsia: QT dispersion, Tp-e interval, and Tp-e/QT ratio.

  2016cites this paper
• dentification and characterization of a novel nanobody against uman placental growth factor to modulate angiogenesis

  2016cites this paper
• Evaluating VEGFR1 genetic polymorphisms as a predisposition to AMD in a cohort from northern China

  2016cites this paper
• Prognostic use of soluble fms-like tyrosine kinase-1 and placental growth factor in patients with coronary artery disease.

  2016cites this paper
• Discovery of pan-VEGF inhibitory peptides directed to the extracellular ligand-binding domains of the VEGF receptors

  2016cites this paper
• Differential expression of vascular endothelial growth factor angiogenic factors in different endometrial compartments in women who have an elevated progesterone level before oocyte retrieval, during in vitro fertilization-embryo transfer treatment.

  2015cites this paper
• Intérêt de la génomique du VEGF en endocrinologie clinique

  2015cites this paper
• Dual Targeting of Angiopoietin-2 and VEGF Signaling for the Treatment of Glioblastoma

  2015cites this paper
• Placental Growth Factor as a Predictor of Cardiovascular Events in Patients with CKD from the NARA-CKD Study.

  2015cites this paper
• Camel Heavy Chain Polyclonal Antibody Raised Against Recombinant Murine Placental Growth Factor Expressed in Escherichia coli

  2015cites this paper
• [Oxidative stress and preeclampsia: A review].

  2015cites this paper
• The regulation of inflammatory liver responses by the TNF ligand and receptor system-TWEAK and Fn14, via human intra-hepatic endothelial cells

  2015cites this paper
• Early gestation chorionic villi-derived stromal cells for fetal tissue engineering.

  2015cites this paper
• Vascular Endothelial Growth Factor: A New Paradigm for Targeting Various Diseases

  2015cites this paper
• Placental Growth Factor Influences Maternal Cardiovascular Adaptation to Pregnancy in Mice1

  2015cites this paper
• Controlled Angiogenesis in Peptide Nanofiber Composite Hydrogels.

  2015cites this paper
• Two-Step Self-Assembly of Liposome-Multidomain Peptide Nanofiber Hydrogel for Time-Controlled Release

  2014cites this paper
• Association of vascular endothelial factors with cardiovascular outcome and mortality in chronic kidney disease patients: a 4-year cohort study.

  2014cites this paper
• The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge

  2014cites this paper
• Trophic factors in the pathogenesis and therapy for retinal degenerative diseases.

  2014cites this paper
• Resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma: from the patient's bed to molecular mechanisms.

  2014cites this paper
• Endothelial dysfunction and preeclampsia: role of oxidative stress

  2014cites this paper
• Matrix density alters zyxin phosphorylation, which limits peripheral process formation and extension in endothelial cells invading 3D collagen matrices.

  2014cites this paper
• Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease

  2014cites this paper
• Priming with proangiogenic growth factors and endothelial progenitor cells improves revascularization in linear diabetic wounds

  2014cites this paper
• Large-scale global identification of protein lysine methylation in vivo

  2013cites this paper
• knock-out mice by promoting de novo leukocyte recruitment Vascular endothelial growth factor-A induces plaque expansion in ApoE

  2013cites this paper
• Enhancement of placenta growth factor expression by oncostatin M in human rheumatoid arthritis synovial fibroblasts

  2013cites this paper
• Plaque-Associated Vasa Vasorum in Aged Apolipoprotein E–Deficient Mice Exhibit Proatherogenic Functional Features In Vivo

  2013cites this paper
• Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models

  2013cites this paper
• Bioassay-guided isolation of proanthocyanidins with antiangiogenic activities.

  2013cites this paper
• G‐Protein coupled receptor 64 promotes invasiveness and metastasis in Ewing sarcomas through PGF and MMP1

  2013cites this paper
• Placental growth factor increases regional myocardial blood flow and contractile function in chronic myocardial ischemia.

  2013cites this paper
• Mechanistic Study of Antiangiogenic Agents in Cancer Therapy

  2013cites this paper
• Bone Vascularization in Normal and Disease Conditions

  2013cites this paper
• Antibody-based antiangiogenic and antilymphangiogenic therapies to prevent tumor growth and progression.

  2013cites this paper
• Pivotal role of the CCL5/CCR5 interaction for recruitment of endothelial progenitor cells in mouse wound healing.

  2012cites this paper
• The role of bone marrow in thrombus resolution

  2012cites this paper
• Behind the scenes of non‐nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes

  2012cites this paper
• Stimulus-dependent phosphorylation of profilin-1 in angiogenesis

  2012cites this paper
• ADAMTS5 functions as an anti-angiogenic and anti-tumorigenic protein independent of its proteoglycanase activity.

  2012cites this paper
• Role of placenta growth factor in cancer and inflammation

  2012influential citation
• Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial

  2012cites this paper
• Mechanisms of Hypoxia-Induced Neurovascular Remodeling in PlGF Knockout Mice

  2012cites this paper
• Angiogenesis in Diabetes. Unraveling the Angiogenic Paradox

  2012cites this paper